Return of infliximab efficacy after total knee arthroplasty in a patient with rheumatoid arthritis [2]

Clinical Rheumatology

Volumn 27, Issue 4, 2008, Pages 549-550

  Toki, Hiroe ^a   Momohara, Shigeki ^a   Ikari, Katsunori ^a   Kawamura, Koichiro ^a   Tsukahara, So ^a   Mochizuki, Takeshi ^a   Sato, Eri ^a   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; INFLIXIMAB; METHOTREXATE; PREDNISOLONE;

ADULT; CASE REPORT; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; KNEE ARTHRITIS; LABORATORY TEST; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; RHEUMATOID ARTHRITIS; SYNOVECTOMY; TOTAL KNEE REPLACEMENT; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, KNEE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 46549084521     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0858-4     Document Type: Letter

References (7)

1. Kanbe K, Inoue K (2006) Efficacy of arthroscopic synovectomy for the effect attenuation cases of infliximab in rheumatoid arthritis. Clin Rheumatol 25(6):877-881
2. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343(22):1594-1602
3. Buch MH, Bingham SJ, Bryer D, Emery P (2007) Long-term infliximab treatment in rheumatoid arthritis: Subsequent outcome of initial responders. Rheumatol (Oxf) 46(7):1153-1156
4. Smolen JS, Van Der Heijde DM, St Clair EW, Emery P, Bathon JM, Keystone E et al (2006) Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial. Arthritis Rheum 54(3):702-710
5. St Clair EW, Wagner CL, Fasanmade AA, Wang B, Schaible T, Kavanaugh A et al (2002) The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: Results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46(6):1451-1459
6. Bombardieri S, Ruiz AA, Fardellone P, Geusens P, McKenna F, Unnebrink K et al (2007) Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice. Rheumatol (Oxf) 46(7):1191-1199
7. Buch MH, Bingham SJ, Bejarano V, Bryer D, White J, Reece R et al (2007) Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept. Arthritis Rheum 57(3):448-453